Viewing Study NCT00022594


Ignite Creation Date: 2025-12-25 @ 1:28 AM
Ignite Modification Date: 2026-05-07 @ 6:21 AM
Study NCT ID: NCT00022594
Status: COMPLETED
Last Update Posted: 2012-07-24
First Post: 2001-08-10
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Liposomal Lurtotecan in Treating Patients With Metastatic or Locally Recurrent Head and Neck Cancer
Sponsor: European Organisation for Research and Treatment of Cancer - EORTC
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Head and Neck Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None recurrent metastatic squamous neck cancer with occult primary View
None metastatic squamous neck cancer with occult primary squamous cell carcinoma View
None stage III squamous cell carcinoma of the lip and oral … View
None stage IV squamous cell carcinoma of the lip and oral … View
None recurrent squamous cell carcinoma of the lip and oral cavity View
None stage III squamous cell carcinoma of the oropharynx View
None stage IV squamous cell carcinoma of the oropharynx View
None recurrent squamous cell carcinoma of the oropharynx View
None stage III squamous cell carcinoma of the hypopharynx View
None stage IV squamous cell carcinoma of the hypopharynx View
None recurrent squamous cell carcinoma of the hypopharynx View
None stage III squamous cell carcinoma of the larynx View
None stage IV squamous cell carcinoma of the larynx View
None recurrent squamous cell carcinoma of the larynx View